FIELD: pharmaceutical industry.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, namely to a composition for oral administration for increasing the content of glutathione in the treatment of cancer selected from liver cancer, rectal cancer, and colon cancer. The composition for oral administration for increasing the content of glutathione in the treatment of cancer selected from liver cancer, rectal cancer, and colon cancer contains a combination of sulforaphane and an extract of milk thistle standardized to the content from 20 to 35 wt.% of silibinin. The composition for oral administration for increasing the content of glutathione in the treatment of cancer selected from liver cancer, rectal cancer, and colon cancer contains a combination of an extract or powder of broccoli standardized to the content from 10 to 20 wt.% of glucoraphanin and an extract of milk thistle standardized to the content from 20 to 35 wt.% of silibinin.
EFFECT: above-described compositions synergistically increase the content of glutathione in the treatment of cancer selected from liver cancer, rectal cancer, and colon cancer.
8 cl, 6 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS COMPRISING A SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MILK THISTLE EXTRACT OR POWDER | 2013 |
|
RU2666953C2 |
COMPOSITIONS CONTAINING SULFORAPHANE OR PRECURSOR OF SULFORAPHANE AND MUSHROOM EXTRACT OR POWDER | 2013 |
|
RU2680387C2 |
METHOD AND REMEDY FOR PREVENTING AND REDUCING UNFAVORABLE MANIFESTATIONS OF ACUTE ALCOHOL INTOXICATION (VERSIONS) AND METHOD FOR PRODUCING THE REMEDY | 2004 |
|
RU2292899C2 |
ENTERIC-COATED GLUCOSINOLATES AND BETA-THIOGLUCOSIDASES | 2008 |
|
RU2477126C2 |
PRODUCTION OF GLUCOSINOLATES OF AGRICULTURAL BY-PRODUCTS AND WASTES | 2008 |
|
RU2466567C2 |
NEW MILK THISTLE EXTRACT, METHOD FOR PREPARING AND USING IT | 2008 |
|
RU2489161C2 |
HEPATOPROTECTIVE AND ANTIHEPATOTOXIC PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATIC DISEASES THAT INVOLVES INTRODUCTION OF SAID COMPOSITION | 2008 |
|
RU2381800C1 |
HORMONAL DISORDERS CORRECTION DEVICE OF REPRODUCTIVE SYSTEM ORGANS | 2019 |
|
RU2712128C1 |
NORMALIZATION OF FUNCTIONS OF BIOLOGICAL PATHWAYS FOR PROTECTION AGAINST AND ELIMINATION OF DISORDERS ARISING FROM HUMAN AGING | 2016 |
|
RU2768936C2 |
SILIBILIN COMPONENT FOR TREATING HEPATITIS | 2008 |
|
RU2482844C2 |
Authors
Dates
2022-12-12—Published
2013-07-03—Filed